Cargando...
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
The incidence of metastatic pheochromocytoma (PHEO) and paraganglioma (PGL) may occur in as many as 35% of patients particularly with PGL and even more frequently in those with specific mutations. Biochemical, morphological, and molecular markers have been investigated for use in the distinction of...
Guardado en:
| Publicado en: | Curr Treat Options Oncol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer US
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7456409/ https://ncbi.nlm.nih.gov/pubmed/32862332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-020-00787-z |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|